<DOC>
	<DOCNO>NCT02203383</DOCNO>
	<brief_summary>Central Sleep Apnoea ( CSA ) affect half patient severe heart failure associate poor prognosis . CSA manifest episode deep breathing intersperse shallow absent breathe largely due exaggerated response rise carbon dioxide blood , normally drive hard breathe . Cardiac Resynchronization therapy ( CRT ) , pacemaker implant improve co-ordinated contraction heart , show reduce severity CSA patient group . We aim determine whether improvement due normalization body 's response carbon dioxide blood . Our hypothesis CRT improve CSA normalize brain 's response carbon dioxide .</brief_summary>
	<brief_title>The Effect CRT Hypercapnic Ventilatory Response</brief_title>
	<detailed_description>Sleep disordered Breathing common heart failure , affect around half patient . This may Obstructive Sleep Apnoea due loss pharyngeal muscle tone ( OSA , associate obesity snore predispose hypertension , heart attack stroke ) Central Sleep Apnoea ( CSA ) . CSA particularly prevalent severe heart failure associate adverse prognosis . The mechanism involve reflex hyperventilation due pulmonary oedema , exaggerate chemosensor response hypercapnoea associate increase sympathetic nervous system activation prolong circulation time . It known CRT improve CSA 'responders ' mechanism unknown . We hypothesis CRT normalize respiratory response carbon dioxide ( hypercapnic ventilatory response - HCVR ) . We screen patient undergo CRT Embletta sleep study identify group moderate severe CSA group sleep apnoea ( control ) . Patients undergo assessment hypercapnic ventilatory response Read Re-Breathe test prior device implantation 6 week 6 month afterwards . The gradient minute ventilation v PaCO2 compare .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>Heart failure reduce ejection fraction ( &lt; 40 % ) Either significant sleep disorder breathe moderate severe CSA Able consent study Ambulatory Aged 18100 year Patients NonInvasive Ventilation Predominant OSA Unable consent attend study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Central Sleep Apnoea</keyword>
	<keyword>Sleep Disordered Breathing</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Hypercapnic Ventilatory Response</keyword>
</DOC>